Position in NVO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$736,598
+$465,420 QoQ
Shares Held
15,365
+108.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#603
of 1,348 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ONE WEALTH CAPITAL MANAGEMENT, LLC holds $4,407,727 across 8 Drug Manufacturers - General names. NVO ranks #3 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758 | $909,168 | |
| 2 | NVS |
Novartis AG
|
5,238 | $820,899 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
15,365 | $736,598 | |
| 4 | AMGN |
Amgen Inc
|
1,698 | $614,879 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,631 | $595,083 | |
| 6 | ABBV |
AbbVie Inc.
|
1,171 | $294,670 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,960 | $228,175 | |
| 8 | JNJ |
Johnson & Johnson
|
820 | $208,255 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $736,598 | 15,365 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $271,178 | 7,379 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $218,834 | 4,301 | Shares | Sole | 2026-02-18 | |
| 2024-12-31 | $437,841 | 5,090 | Shares | Sole | 2025-01-07 | |
| No filing history on record for this holder in this stock. | ||||||